Primary Site >> Stomach Cancer

Gene >> UGT1A

Journal: Ann Oncol. 2011 Apr;22(4):890-6.
Title: Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.
Author: Park, S R|Kong, S-Y|Rhee, J|Park, Y-I|Ryu, K W|Lee, J H|Kim, Y-W|Choi, I J|Kim, C G|Lee, J Y|Cho, S-J|Kim, N K
PMID: 20860988
Journal: Tohoku J Exp Med. 2013 Feb;229(2):107-14.
Title: Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy.
Author: Inoue, Kazuyuki|Sonobe, Momoyo|Kawamura, Yukinori|Etoh, Takashi|Takagi, Masakazu|Matsumura, Takashi|Kikuyama, Masataka|Kimura, Midori|Minami, Sato|Utsuki, Hiroaki|Yamazaki, Tomoaki|Suzuki, Takayo|Tsuji, Daiki|Hayashi, Hideki|Itoh, Kunihiko
PMID: 23303296
Journal: Med Oncol. 2013;30(3):630.
Title: Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients.
Author: Gao, Jing|Zhou, Jun|Li, Yanyan|Peng, Zhi|Li, Yilin|Wang, Xicheng|Shen, Lin
PMID: 23783485